A comparison of neoadjuvant chemotherapy with gemcitabine versus docetaxel plus cisplatin in locoregionally advanced nasopharyngeal carcinoma: a propensity score matching analysis

PURPOSE: To compare the efficacy and safety of neoadjuvant chemotherapy (NACT) with gemcitabine (GEM) vs docetaxel plus cisplatin (CDDP) in locoregionally advanced nasopharyngeal carcinoma (NPC). METHODS: A total of 222 patients with locoregionally advanced NPC between February 2012 and May 2014 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tongxin, Sun, Quanquan, Chen, Jing, Wang, Fangzheng, Li, Bin, Qin, Weifeng, Ye, Zhimin, Hu, Fujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260124/
https://www.ncbi.nlm.nih.gov/pubmed/30538570
http://dx.doi.org/10.2147/CMAR.S186233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260124/
https://www.ncbi.nlm.nih.gov/pubmed/30538570
http://dx.doi.org/10.2147/CMAR.S186233

Ejemplares similares